Skip to main content

Day: December 23, 2025

Radware Reports Results of 2025 Annual General Meeting

TEL AVIV, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced the results of its Annual General Meeting of Shareholders held December 22, 2025. The Company presented four proposals for the shareholders to vote on at the meeting, of which one proposal (to approve compensation terms of, including grants of equity-based awards to, non-employee directors and related amendments to the Compensation Policy) was not adopted by the requisite shareholder vote. The three other proposals voted on at the Annual General Meeting were adopted by the requisite shareholder vote. About Radware Radware® (NASDAQ: RDWR) is a global leader in application security and delivery solutions for multi-cloud environments. The company’s...

Continue reading

Baltic Horizon Fund financial calendar for 2026

Baltic Horizon Fund intends to disclose financial results and arrange the general meeting of investors according to the following schedule in 2026:Interim Financial Statements for 12 months of 2025                   17 February 2026Audited annual report for 2025                                                      31 March 2026Audited annual report for 2025 of the management company Baltic Horizon Capital AS     23 April 2026Interim Financial Statements for 3 months of 2026                       7 May 2026Annual General Meeting of investors                                        1 June 2026Interim Financial Statements for 6 months of 2026                       6 August 2026Interim Financial Statements for 9 months of 2026                       5 November 2026Interim Financial Statements for 12 months of 2026   ...

Continue reading

InnoCare Announces NMPA Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Cutaneous Lupus Erythematosus

BEIJING, Dec. 23, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) to conduct a phase II clinical trial of its novel TYK2 inhibitor ICP-488 for the treatment of cutaneous lupus erythematosus (CLE). ICP-488 is an oral, potent, and selective TYK2 allosteric inhibitor. By binding to the JH2 domain, ICP-488 blocks the signal transduction of IL-23, IL-12, type 1 IFN, and other inflammatory cytokines, thereby inhibiting the pathological processes of autoimmune and inflammatory diseases. CLE is a common type of lupus erythematosus, an autoimmune disease that...

Continue reading

Form 8.3 – [IQE PLC – 22 12 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [IDOX PLC – 22 12 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Virtune lists Virtune Staked Ethereum ETP and Virtune Chainlink ETP on Deutsche Börse Xetra in Germany

Frankfurt, 23rd of December 2025 – Swedish regulated crypto asset manager Virtune lists Virtune Staked Ethereum ETP and Virtune Chainlink ETP on Deutsche Börse Xetra, expanding its offering of physically backed crypto exchange-traded products in the German market. Virtune, a Swedish digital asset manager and issuer of physically backed crypto exchange-traded products (ETPs), has earned the trust of over 155.000 investors since its launch just over two years ago. With more than USD $330 million in assets under management (AUM), Virtune continues to strengthen its position as one of the leading issuers of regulated crypto ETPs across Europe. Virtune is now expanding its German offering with the listing of Virtune Staked Ethereum ETP and Virtune Chainlink ETP. This listing reflects Virtune’s commitment to offering German investors secure,...

Continue reading

Subsea 7 – awarded contract offshore US

Luxembourg – 23 December 2025 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by LLOG Exploration Offshore L.L.C., for the Buckskin South Expansion project. The Buckskin field is located approximately 305 kilometres off the coast of Texas, in the US. The scope of work includes the transportation and installation of a subsea umbilical and a rigid flowline in water depths of up to 2,100 metres. Project management and engineering activities will begin immediately from Subsea7’s Houston, Texas office, with offshore operations scheduled for 2026 and 2027. Craig Broussard, Senior Vice President for Subsea7 Gulf of Mexico, said: “We are proud to continue working alongside LLOG to deliver greater value from their US developments, building on successes such as the innovative Salamanca project,...

Continue reading

Michelin: Disclosure of trading in own shares – December 23, 2025

23, Place des Carmes-Déchaux – 63000 CLERMONT-FERRAND Information about securities repurchasing programRegulated informationIssuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of securities: ordinary shares – Code ISIN FR001400AJ45Date : December 23rd, 2025Issuer Name Issuer code Transactiondate ISIN Code Daily total volume (in number of actions) Daily weighted average price of shares acquired PlatformCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 23.12.2025 FR001400AJ45 890 932 28,0605 euros Over-the-counterCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 23.12.2025 FR001400AJ45 356 373 28,0605 euros Over-the-counterIssuer Name Issuer code PSIName Issuer Code Transaction date   ISIN Code Unit Price Currency Quantity bought Platform Transaction reference number Buyback...

Continue reading

Vantiva Board of Directors Elects Katleen Vandeweyer as Chairwoman of the Board

Press Release Vantiva Board of Directors Elects Katleen Vandeweyer as Chairwoman of the Board Current Lead Independent Board Member Katleen Vandeweyer takes on the Chairperson role as Brian Shearer transitions off Vantiva’s Board of Directors. Paris, France – December 23, 2025 – Vantiva (Euronext Paris: VANTI), a global technology leader enabling Network Service Providers to connect consumers worldwide, today announces leadership changes on its Board of Directors. Independent Board Director Katleen Vandeweyer has been voted into the Chairperson role. Katleen has a strong background in business management with solid telecommunications experience. She has recently been providing significant contributions to some high-profile boards in the EU. In connection with the appointment and in consultation with the Board and Vantiva leadership, Brian...

Continue reading

Sampo plc’s share buybacks 22 December 2025

Sampo plc, stock exchange release, 23 December 2025 at 8:30 am EET Sampo plc’s share buybacks 22 December 2025 On 22 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  7,597 10.22 AQEU    113,472 10.23 CEUX  22,320 10.24 TQEX  111,906 10.23 XHELTOTAL 255,295 10.23  * rounded to two decimals                      On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.